Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies
- DOI
- 10.3389/fphar.2026.1789833
- Published
- 2026-08-03
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1789833,
title = {Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies},
author = {Youssuf Khanafer and Ayman Dalol and Ahmed Z. El-Hashim and Ibrahim F. Benter and Saghir Akhtar},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1789833},
url = {https://doi.org/10.3389/fphar.2026.1789833}
}RIS
TY - JOUR TI - Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies AU - Youssuf Khanafer AU - Ayman Dalol AU - Ahmed Z. El-Hashim AU - Ibrahim F. Benter AU - Saghir Akhtar PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1789833 UR - https://doi.org/10.3389/fphar.2026.1789833 ER -
APA
Khanafer, Y., Dalol, A., El-Hashim, A. Z., Benter, I. F., & Akhtar, S. (2026). Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1789833
Source records
- crossref · retrieved 2026-09-26T10:04:58.768Z